COAs
Certificates of Analysis (COAs) are frequently cited in community discussions as proof of product quality. This page explains what a COA actually tests, what it cannot verify, and why COAs are insufficient to establish safety for human use.
COA interpretation requires analytical chemistry expertise. TryTrutide provides general context only.
Common Claims — Fact-Checked
These claims appear frequently in community discussions. Each is evaluated against the best available clinical evidence.
"A COA proves the retatrutide is real and safe."
✗UnsupportedA COA from a third-party lab tests the sample submitted by the vendor — not a random sample from production. It cannot verify that the product you receive matches the tested sample. It tests for specific analytes; it does not screen for all possible contaminants. It does not establish safety for human use.
"99% purity on a COA means the product is 99% pure retatrutide."
?Context NeededPurity testing by HPLC measures the proportion of the main peak relative to other peaks in the chromatogram. It does not identify what the main peak is — only that it is the dominant component. A product could be 99% pure semaglutide and pass a retatrutide purity test if the lab is not using a retatrutide-specific reference standard.
Evidence Summary
COA limitations: (1) tests the submitted sample, not production batches; (2) HPLC purity does not confirm identity without a reference standard; (3) does not screen for all contaminants; (4) does not establish safety for human use; (5) can be fabricated. COAs are a minimum quality indicator, not a safety guarantee.
Analyzed Threads
These threads were selected for editorial analysis. TryTrutide does not link to Reddit posts.
"Which research peptide supplier has the best retatrutide?"
✗UnsupportedClaim: Community members regularly share and rank grey-market peptide suppliers offering retatrutide, claiming some suppliers have "pharmaceutical grade" product verified by third-party testing.
Retatrutide has not received FDA approval as of September 2026. No commercial pharmaceutical-grade retatrutide exists outside of clinical trial supply. Products sold by research peptide suppliers are not manufactured under FDA cGMP conditions, have not been evaluated for sterility, potency, or purity by any regulatory body, and cannot legally be sold for human use. Third-party certificates of analysis (COAs) from peptide suppliers test for molecular identity (typically by HPLC or mass spec) but do not assess sterility, endotoxin levels, or the presence of process impurities that could cause serious adverse events. The FDA has issued warning letters to suppliers of similar unapproved peptides.
Reddit Observatory
26 topic categories — community claims vs. clinical evidence
Want a Physician to Review Your Eligibility?
Retatrutide is not yet FDA approved. A physician can review your health profile and discuss investigational access options.
Start Physician Review